2026 NPPES data Nuclear Medicine Physician NPI 1699855841 DO
Verify on CMS →

PAUL LIZOTTE, DO

Nuclear Medicine Physician in OCEANSIDE, California. CMS National Plan and Provider Enumeration System profile including specialty classification, practice address, and Medicare prescribing data when reported.

Federal data — no proprietary rating. PlainDoctor publishes the actual CMS NPPES and Medicare records — NPI registration, specialty, practice location, and prescribing data — without a composite score or editorial opinion on top. Every field traces to a federal source.
Prescribing volume
3K
Medicare Part D claims · 238 beneficiaries · Nuclear Medicine Physician avg: 881
Generic prescribing
86%
generic claims · 14% brand-name · higher generic rates reduce patient out-of-pocket costs
Industry payments
$121.47
7 payments · CMS Open Payments (Sunshine Act)
What the federal data reveals: PAUL LIZOTTE, DO is a Nuclear Medicine Physician ([object Object]) practicing in OCEANSIDE, California with a Medicare Part D prescribing footprint of 3K claims across 238 beneficiaries — 14% brand-name prescribing . Industry payments of $121.47 across 7 transactions are disclosed under CMS Open Payments (Sunshine Act).

What stands out: PAUL LIZOTTE, DO filed 3,075 Medicare Part D claims in 2023 across OCEANSIDE, California. Every figure on this page comes straight from federal CMS records, with no proprietary rating applied.

Board-eligible specialty (heuristic — not verified)

PAUL LIZOTTE, DO practices in an ABMS-board-eligible specialty but we don't have enough CMS-participation signals to confirm active board-certified status. Consult CertificationMatters.org (the official ABMS public lookup).

PAUL LIZOTTE, DO at a glance

Quality data not reported

NPI registry status

Active

Issued 10/16/2006

NPI 1699855841

Primary specialty

Nuclear Medicine Physician

Niche

913 US NPIs in this specialty

Medicare Part D claims

3,075 249% vs specialty avg

2023 prescription claims

Specialty avg: 881

Specialty distribution in California

How Nuclear Medicine Physician compares to other specialties among California providers

California providers

Nuclear Medicine Physician share within California

1. Nuclear Medicine Physician42%2. Internal medicine21%3. Family medicine17%4. Surgical12%5. Pediatric8%
Nuclear Medicine Physician share within California

Specialty board-certification context

Estimated specialty board-certified rate — Nuclear Medicine Physician (ABMS / AOA reference)

Quality data not reported
Est. board-certified rate
78%
Nuclear Medicine Physician ABMS/AOA estimate

Est. board-certified rate (Nuclear Medicine Physician) — ABMS / AOA estimate

0%100%78%
Est. board-certified rate (Nuclear Medicine Physician) — ABMS / AOA estimate

The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.

Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).

PAUL LIZOTTE, DO is a Nuclear Medicine Physician provider practicing in OCEANSIDE, California, according to the CMS National Plan and Provider Enumeration System (NPPES). Credentials: DO. NPI: 1699855841. This profile includes practice location, specialty classification, and organizational affiliations from the CMS provider registry. Provider information is self-reported to CMS and updated monthly.

PAUL LIZOTTE, DO appears in the CMS NPPES registry as a Nuclear Medicine Physician provider holding DO credentials at 115 NORTH EL CAMINO REAL SUITE A, OCEANSIDE, CA, 92058, with a listed phone of (760) 330-5055. NPI 1699855841 was issued on 10/16/2006. Because NPPES data is self-reported by the provider and refreshed monthly, the address, phone, and specialty reflect what LIZOTTE most recently submitted to CMS rather than a vetted directory listing, which is why patients should always confirm the practice is still at this location before scheduling.

Medicare Part D records for calendar year 2023 show 3,075 prescription claims written by this provider, covering 238 Medicare beneficiaries and totaling roughly $399K in drug spend, split 14% brand-name and 86% generic by claim count, with an opioid prescribing rate of 3.1%. These figures capture only Medicare Part D — commercial insurance, Medicaid, and cash-pay prescriptions are not included, and any drug-beneficiary cell under 11 is suppressed by CMS for patient privacy.

Nuclear Medicine Physician is a narrow specialty nationwide, with 913 enrolled providers across 48 states and an average of 881 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline. Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist — always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.

Practice Address

115 NORTH EL CAMINO REAL SUITE A
OCEANSIDE, CA 92058

Provider Details

NPI 1699855841
Specialty Nuclear Medicine Physician
Credentials DO
Gender Male
NPI Issued 10/16/2006

Industry payments received (2024) — CMS Open Payments transparency data

The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for PAUL LIZOTTE, DO. Source: openpaymentsdata.cms.gov.

Total received

$121

Largest payer

AstraZeneca Pharmaceuticals LP

Most common payment type

Food and Beverage

Industry payments are not necessarily indicators of bias — they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.

License & disciplinary context — California MBC 2023 annual report

Aggregate state board data only — NOT a determination of any individual provider's status. The figures below describe statewide disciplinary activity across all ~150K California medical licensees in 2023 — they are NOT specific to PAUL LIZOTTE, DO. To verify PAUL LIZOTTE, DO's current license status, search the MBC public license lookup directly, or check the Federation of State Medical Boards (FSMB) verification service.

576
Total board actions, California 2023
Across 556 cases
3.84
Actions per 1,000 licensees
California statewide rate
probation
Most common action type
186 cases

MBC publishes annual disciplinary statistics as part of public-record reporting under each state's Administrative Procedure Act. See the full breakdown by action type and year on the California disciplinary trends page. Cross-checked against FSMB U.S. Medical Regulatory Trends.

Brand vs generic prescribing mix · Typical

PAUL LIZOTTE, DO — brand share 14.0%
Specialty average (est.)

14% brand-name claims vs 86% generic, on 3,075 2023 Medicare Part D claims.

The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.

Medicare Part D Prescribing Data

CMS Medicare Part D prescriber-level data for calendar year 2023.

3,075
Total Claims
$399K
Total Drug Cost
238
Medicare Beneficiaries

Prescribing Breakdown

30-Day Fills
6,336
Total Day Supply
182,402
Brand vs Generic
14% brand / 86% generic
Brand Drug Cost
$330K
Generic Drug Cost
$67K
Opioid Claims
96 (3.1% rate)
Antibiotic Claims
104

Patient Demographics

Average Patient Age
72.5 years
Avg HCC Risk Score
1.21
Gender Split
52% female / 48% male
Age Distribution
<65: 18, 65-74: 131, 75-84: 67, 85+: 22

Top Prescribed Drugs (Medicare Part D)

Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.

Drug Claims
Rosuvastatin Calcium
165
Atorvastatin Calcium
132
Amlodipine Besylate
121
Levothyroxine Sodium
120
Lisinopril
100
Metformin Hcl
75
Trulicity
Dulaglutide
68
Losartan Potassium
65
Jardiance
Empagliflozin
63
Pantoprazole Sodium
60

* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.

Nuclear Medicine Physician Overview

How PAUL LIZOTTE, DO fits within the Nuclear Medicine Physician landscape nationally.

913
Nuclear Medicine Physician Providers in US
48
States with Nuclear Medicine Physician
881
Avg Claims per Provider

PAUL LIZOTTE, DO's 3,075 claims are above the specialty average of 881.

Nearby Nuclear Medicine Physician Providers in California

Other clinicians with the same primary specialty enrolled in California, drawn from the same CMS NPPES roster as LIZOTTE.

Compare Nuclear Medicine Physician nationally: see state-by-state distribution →

Frequently Asked Questions

What is PAUL LIZOTTE, DO's specialty?
PAUL LIZOTTE, DO specializes in Nuclear Medicine Physician and practices in OCEANSIDE, California. Credentials: DO.
How much does PAUL LIZOTTE, DO prescribe under Medicare Part D?
In 2023, PAUL LIZOTTE, DO wrote 3,075 Medicare Part D claims totaling $399K in drug costs for 238 beneficiaries.
Where is PAUL LIZOTTE, DO located?
PAUL LIZOTTE, DO is located at 115 NORTH EL CAMINO REAL SUITE A, OCEANSIDE, CA, 92058. Phone: (760) 330-5055.
What is PAUL LIZOTTE, DO's NPI number?
PAUL LIZOTTE, DO's National Provider Identifier (NPI) is 1699855841, issued on 10/16/2006.
Does PAUL LIZOTTE, DO prescribe more brand-name or generic drugs?
PAUL LIZOTTE, DO's prescribing is 14% brand-name and 86% generic drugs by claim count, with $330K in brand drug costs.
Does PAUL LIZOTTE, DO prescribe opioids?
Yes, PAUL LIZOTTE, DO had 96 opioid claims in 2023 with an opioid prescribing rate of 3.1%.
How many Nuclear Medicine Physician providers are there in the US?
There are 913 Nuclear Medicine Physician providers across 48 states in the US. The average Nuclear Medicine Physician provider writes 881 Medicare Part D claims per year.
What drugs does PAUL LIZOTTE, DO prescribe most often?
Based on 2023 Medicare Part D data, PAUL LIZOTTE, DO's most frequently prescribed drugs include Rosuvastatin Calcium, Atorvastatin Calcium, Amlodipine Besylate. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does PAUL LIZOTTE, DO accept Medicare?
PAUL LIZOTTE, DO appears in CMS Medicare data with 3,075 Part D claims and 238 Medicare beneficiaries in 2023. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify PAUL LIZOTTE, DO's credentials?
PAUL LIZOTTE, DO's NPI is 1699855841 with credentials DO. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.

Data Sources

Provider Directory
CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
Specialty Classification
NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
Prescribing Data
CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
Limitations
Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.

See our complete data methodology for details on how we collect and process government data.

Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).

Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology